Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
出版年份 2023 全文链接
标题
Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
作者
关键词
-
出版物
OPHTHALMOLOGY
Volume 130, Issue 7, Pages 735-747
出版商
Elsevier BV
发表日期
2023-03-03
DOI
10.1016/j.ophtha.2023.02.024
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
- (2022) Jeffrey S Heier et al. LANCET
- Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration
- (2022) Margaret A. Chang et al. JAMA Ophthalmology
- The learning curve of retinal detachment surgery
- (2021) Viola Radeck et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2021) Nancy M. Holekamp et al. OPHTHALMOLOGY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
- (2019) Pravin U. Dugel et al. OPHTHALMOLOGY
- Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration
- (2018) Vincent Daien et al. OPHTHALMOLOGY
- Glaucoma Gel Implant Learning Curve in a Teaching Tertiary Hospital
- (2018) Raquel Esteves Marques et al. JOURNAL OF GLAUCOMA
- Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up
- (2016) Donald L. Budenz et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema
- (2016) David G. Callanan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- The Ahmed Versus Baerveldt Study
- (2016) Panos G. Christakis et al. OPHTHALMOLOGY
- Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study
- (2015) Jonathan L. Prenner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Caregiver perceptions about the impact of caring for patients with wet age-related macular degeneration
- (2015) M Vukicevic et al. EYE
- Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
- (2015) Travis A. Meredith et al. OPHTHALMOLOGY
- Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
- (2015) Marc C. Peden et al. OPHTHALMOLOGY
- Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration
- (2015) Rishma Gohil et al. PLoS One
- Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration
- (2014) Allen C. Ho et al. OPHTHALMOLOGY
- Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
- (2014) David S. Boyer et al. OPHTHALMOLOGY
- Three-year Treatment Outcomes in the Ahmed Baerveldt Comparison Study
- (2014) Keith Barton et al. OPHTHALMOLOGY
- Use of Mitomycin C to reduce the incidence of encapsulated cysts following ahmed glaucoma valve implantation in refractory glaucoma patients: a new technique
- (2014) Minwen Zhou et al. BMC Ophthalmology
- Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
- (2013) Brandon G. Busbee et al. OPHTHALMOLOGY
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
- (2013) Soraya Rofagha et al. OPHTHALMOLOGY
- Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
- (2013) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More